This is a prospective study of breast cancer risk in relation to nipple aspirate fluid cytology in 2,701 volunteer white women from the San Francisco Bay Area first enrolled between 1973 and 1980. The women were not pregnant or lactating and were free of breast cancer within 6 months of entry into the study. The breast cancer status of this cohort was determined between June 1988 and April 1991. Follow-up was complete for 87% (n = 2,343) of the cohort, representing 29,961 person-years and an average of 12.7 years of follow-up. The overall breast cancer incidence was 4.4% (104 of 2,343) and rose with fluid cytology findings as follows: no fluid obtained, 2.6% (9 of 352); unsatisfactory specimen, 4.8% (15 of 315); normal cytology, 4.3% (56 of 1,291); epithelial hyperplasia, 5.5% (18 of 327); and atypical hyperplasia, 10.3% (6 of 58). Relative risks for breast cancer and their 95% confidence intervals were estimated by Cox regression, adjusting for age and year of entry. Compared with the relative risk for women who yielded no fluid, relative risks were: unsatisfactory specimen, relative risk (RR) = 1.4 (95% confidence interval (Cl) 0.6-3.3); normal cytology, RR = 1.8 (95% Cl 0.9-3.6); epithelial hyperplasia, RR = 2.5 (95% Cl 1.1-5.5); and atypical hyperplasia, RR = 4.9 (95% Cl 1.7-13.9). These findings were strongest for and were mainly confined to women aged 25-54 years. Women with atypical hyperplasia and a firstdegree family history of breast cancer were six times more likely to develop breast cancer than were women with atypical hyperplasia but without a family history of breast cancer (95% Cl 1.0-30.2). These findings provide strong support for our hypothesis that hyperplasia and atypical hyperplasia diagnosed in nipple aspirates of breast fluid are associated with an increased risk of breast cancer. Am J Epidemiol 1991 ;135:130 41. breast; breast neoplasms, etiology; breast, secretion; cohort studies; cytology; neo plasms; risk factors For the past 18 years, we (1 -4) have in-and cytologic features of breast fluid ob vestigated the epidemiologic, biochemical, tained by nipple aspiration and the interre-
lations of these components of breast fluid nant nor lactating at entry into the study, to benign breast disease and breast cancer.
were free of breast cancer, and did not de The simple, noninvasive technique of nipple velop breast cancer within 6 months of en aspiration has permitted us to evaluate bio try. Their characteristics have been de chemical constituents of nipple aspirate fluid scribed elsewhere (11) . Briefly, the women and the status of exfoliated breast epithelial were volunteers from various outpatient cells in a high proportion of adult nonpreg clinics at the University of California, San nant women. Four factors have been con Francisco (35 percent), the Breast Cancer sistently associated with increased ability to Detection and Diagnosis Project of the obtain breast fluid: 1) age 35-50 years; 2) American Cancer Society/National Cancer early age at menarche; 3) non-Asian versus Institute at the Breast Screening Center of Asian ethnicity; and 4) history of parity and/ Northern California, Merritt Hospital, Oak or lactation (4) . These and other aspects of land, California (59 percent), and other the epidemiology, cytopathology, and bio community sources, such as local health chemistry of nipple aspirate fluid were re fairs and screening programs (6 percent). cently reviewed (2) (3) (4) (5) . Recent evidence sug
The women were self-referred or were re gests that dietary fat intake may influence ferred by physicians. Potential risk factors breast fluid secretion (6) .
for breast cancer were assessed with a struc tured questionnaire and included age, family On the basis of the most severe epithelial history of breast cancer, parity, ethnicity, changes observed, we have classified the cy other demographic factors, and reproductive tology of nipple aspirate fluid samples as and medical histories. hyperplasia, moderate hyperplasia, atypical hyperplasia, or malignant (5) (6) (7) (8) . In an earlier
Nipple aspirate fluid was obtained by the study, King et al. (9) reported a significant method of Sartorius et al. (12) . A small concordance of cytopathologic findings in plastic cup attached to a 10-cc syringe by a nipple aspirates with the histopathologic short plastic tube was placed over the nipple, findings from biopsy specimens. However, which had been previously cleaned with a while demonstrating an association of atyp detergent. While the subject gently com ical hyperplasia and breast cancer, that study pressed the breast with both hands, the sy could not directly address whether cytopath ringe was retracted to the 5-6 ml mark. If ologic changes detected in nipple aspirate fluid did not appear at the nipple surface fluid preceded the development of benign or within 5 seconds, the plunger was withdrawn malignant breast disease. Except for a pre to the full 10 ml mark and held for an liminary positive assessment (10) , the prog additional 10-15 seconds. If no fluid ap nostic value of nipple aspirate cytology has peared within this time, the subject was des not been determined.
ignated as a nonyielder. The fluid appearing To our knowledge, this paper presents the at the nipple surfaces was collected in cap results of the first prospective study of the illary tubes and processed for cytology by risk of breast cancer by nipple aspirate fluid the techniques previously described by King cytologic diagnosis in a cohort of 2,701 et al. (5, 9) . The cytologic diagnosis of epi women who underwent nipple aspiration of thelial and other cell types was noted by our breast fluid 10-18 years previously.
project pathologist (E. B. K.) on standard ized coding forms using criteria described in detail elsewhere (9) . Each breast fluid speci men was classified according to the most
MATERIALS AND METHODS
severe epithelial change present, i.e., normal, ling for age at entry into the study) in women with different cytologic diagnoses compared Breast cancer status was initially ascer with nonyielders. Separate models were used tained through self-reports or next-of-kin re that combined the categories of unsatisfac ports of breast cancer or of malignant find tory specimen and normal cytology. Further ings in biopsy or mastectomy, and subse analyses also controlled for parity (nullipa quently by pathology reports and slides from rous vs. parous), place of examination, and hospitals and medical care providers for all first-degree family history of breast cancer. identified biopsies and mastectomies. Breast Separate logistic and Cox models were fit cancer incidence was also determined from using either the most severe cytologic find death certificate designation and the San ings from any visit for women who had more Francisco Bay Area Tumor Registry. Slides than one visit or using results from the first and pathology reports were reviewed by our visit only. We reconstructed missing data on project pathologist (E. B. K.) and recorded parity status at the time of entry into the and coded on a standardized form, using study or on the date of the most severe definitions consistent with those of others cytologic diagnosis by using information and based on our experience (9, (14) (15) (16) .
from the follow-up questionnaire. We used reports of no first-degree relative with breast In addition to internal comparisons of breast cancer risk within the cohort of women, using data from the SEER registry we compared the observed number of inva sive breast cancer cases among white women in the cohort with the number of breast cancer cases expected if the women had risk comparable with white women in the San Francisco-Oakland Standard Metropolitan Statistical Area (SMSA) for the time period under study. Under the null hypothesis that the incidence of breast cancer is the same in women irrespective of cytologic diagnosis, we would expect each woman to have the same age-dependent risk of developing breast cancer at any age. We assumed this risk to be equal to the average annual agespecific incidence rate of breast cancer among white females in the San FranciscoOakland SMSA for three time periods. We [1985] [1986] [1987] [1988] [1989] [1990] . Each woman's probability of not developing breast cancer during the entire period from entry into the study through the end of 1990 was computed as the cumulative product of her probabilities of not developing breast cancer at each year. Her probability of not developing breast cancer in any year was taken as one minus the probability of devel oping breast cancer at her age during that year. Age was incremented 1 year for each year of follow-up, and each woman's ex pected risk of breast cancer was taken as one minus her cumulative risk of not developing breast cancer over the entire study period. The number of women expected to develop breast cancer was then the sum of each woman's risk over all women.
RESULTS

Description of the cohort and follow-up
Baseline nipple aspirate fluid findings, de mographics, and risk factor data for the Abnormal Cytology and Breast Cancer Risk 133 women in whom follow-up was completed and for those not traced are shown in table 1. Overall, follow-up was completed for 87 percent (2,343 of 2,701) of the women. The women with completed follow-up were more likely to be ages 35-70 years at entry, to have a first-degree relative with breast cancer, and to be parous. A total of 29,961 person-years of follow-up, an average of 12.7 years, was completed on these women. Among the 1,991 women from whom nipple aspirate fluid was obtained, cytologic diag noses were based on the most severe finding in the specimens obtained at a single visit develop breast cancer than were women who for 1,792 (90 percent) women; at two visits did not yield fluid (95 percent CI 1.1-5.5) for 159 (8 percent) women; and at three or and 1.4 times more likely to develop breast more visits for 40 (2 percent) women. Nipple cancer than were women with normal cyto aspirate fluid satisfactory for cytoiogic diag iogic findings (95 percent CI 0.8-2.4). nosis was obtained from 80 percent of Women with atypical hyperplasia were 4.9 women who were age 25-54 years, but from times more likely to develop breast cancer only 50 percent of women aged 55 or over.
than were nonyielders of fluid (95 percent As of April 1991, 104 of 2,343 (4.4 per CI 1.7-13.9) and 2.8 times more likely to cent) of the women had developed breast develop breast cancer than were women with cancer since they were originally enrolled in normal cytoiogic findings (95 percent CI the study. Of the 104 cases, six (5.8 percent)
1.2-6.4). were solely self-reported and two (1.9 per
As shown in figure 1 , the increased cu cent) were identified only on death certifi mulative breast cancer incidence among cates; the remaining 92.3 percent of cases women with atypical hyperplasia compared were confirmed either through the tumor with women who did not yield fluid or with registry or through pathology review by the women with hyperplasia or normal findings project pathologist. A total of 10.6 percent was apparent at all time intervals since entry (11 of 104) of identified breast cancers were into the study. The cumulative incidence of carcinoma in situ.
breast cancer in women with hyperplasia also was consistently higher than it was in women with normal cytology or in those
Breast cancer incidence by cytoiogic who did not yield fluid.
diagnosis
Ages 25-54 years versus ages 55 and All ages. A progressive increase in inci
older. We examined the association of breast dence and relative risk of breast cancer was cancer risk and cytology in two separate age found by severity of cytoiogic diagnosis (ta groups because over all ages there was a ble 2). Women from whom fluid was ob highly significant (p < 0.01) interaction be tained that was unsatisfactory for diagnosis tween age and cytology on breast cancer risk. or contained normal cytology were 1.4 and The increase in breast cancer incidence and 1.8 times more likely to develop breast can relative risk with abnormal cytoiogic find cer than were women from whom nipple ings was more pronounced in women who aspirate fluid could not be obtained (relative were aged 25-54 years compared with risk (RR) for the two categories combined = women who were age 55 years or older at 1.7, 95 percent confidence interval (CI)0.8 the time of specimen collection (table 3) .
3.4). Women with epithelial hyperplasia
Among the former, those with normal cy were approximately 2.5 times more likely to toiogic findings or with fluid unsatisfactory for cytologic diagnosis were six to seven Women with and those without a firsttimes more likely to develop breast cancer degree family history of breast cancer. than were women from whom nipple aspi Women of all ages with both a first-degree rate fluid could not be obtained (RR for the relative with breast cancer and a cytologic two categories combined = 6.4; 95 percent diagnosis of hyperplasia or atypical hyper CI 0.9-46.4). Women with epithelial hyper plasia were at particularly increased risk of plasia were 9.5 times more likely to develop breast cancer (table 4) . Among women with breast cancer than were nonyielders of fluid a first-degree family history of breast cancer, (95 percent CI 1.3-71.7), and 1.5 times more women with atypical hyperplasia had 7.2 likely to develop breast cancer than were times the risk of breast cancer as did women women with normal cytologic findings (95 with normal cytology (95 percent CI 2.0 percent CI 0.8-2.7). Women with atypical 26.0). Among women with cytologic atypi hyperplasia were 16.3 times more likely to cal hyperplasia, those with a first-degree develop breast cancer than were nonyielders family history of breast cancer were approx of fluid (95 percent CI 1.9-139.3), and 2.6 imately six times more likely to develop times more likely to develop breast cancer breast cancer than those without such family than were women with normal cytologic history (95 percent CI 1.0-30.2). In contrast, findings (95 percent CI 1.0-6.5).
a first-degree family history of breast cancer conferred no significant increase in risk of In contrast to the increased risks found in breast cancer among women who did not younger women, among women age 55 years yield fluid upon nipple aspiration (RR = and over at time of specimen collection, no 1.3, 95 percent CI 0.3-6.3). Because of the significant or consistent differences were small number of women with a family his found in risk of breast cancer by the differing tory of breast cancer, it was not feasible to cytologic diagnoses (table 3) . further stratify the analyses according to ages only for age and year of entry. Similar rela younger than 55 years versus those age 55 tive risks were found when the analyses also or older.
controlled for parity and place of examinaThe results presented here were controlled tion.
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Comparison of observed with expected number of breast cancer cases using SEER rates for the San Francisco-Oakland SMSA. As shown in table 5, the white women com prising our cohort were only 3 percent more likely to develop breast cancer than were all white women in the San Francisco-Oakland SMSA during the study period. When the results were broken down by cytologic di agnosis, we found that women with hyper plasia or atypical hyperplasia were more likely than all women to develop breast can cer and that those who did not yield fluid upon nipple aspiration were less likely to develop breast cancer. Of the 10 women with both atypical hyperplasia and a first-degree family history of breast cancer, we observed three cases of breast cancer compared with an expected 0.42 using the SEER rates, giv ing a ratio of 7.1.
DISCUSSION
In the pathogenesis of breast cancer, breast epithelial cells are believed to progress from their normal state through morphologically identifiable stages of mild hyperplasia, mod erate hyperplasia, and atypical hyperplasia to carcinoma in situ and cancer (14, 22, 23) . However, it is not established that all breast cancers arise from this sequence of prolifer ative lesions. It is possible that in susceptible women, inherited or acquired gene muta- tions or deletions that effect the regulation of differentiation might result in direct trans formation of normal cells to cancer, without passing through the intermediate stages. Ir respective of these mechanistic considera tions, it is now widely accepted that hyper plasia and atypical hyperplasia, when diag nosed in breast biopsies, are morphologic markers that are associated with a two-to fivefold increased risk of breast cancer (14, (22) (23) (24) (25) (26) . Studies also have shown that in creased risks associated with proliferative or atypical histopathologic findings may be modified by other risk factors for breast cancer, particularly a positive family history of breast cancer (15, 25, 26) . However, the great majority of women who develop breast cancer have never undergone a breast bi opsy, and the status of their breast epithelia prior to the diagnosis of cancer is unknown (27). Of further importance, less than 15 percent of women with breast symptoms or physical findings have ever undergone a breast biopsy (27, 28), and less than 5 per cent of these biopsy specimens are diagnosed as atypical hyperplasia (15, 29) . Moreover, less than 15 percent of women who develop breast cancer have a history of a previous breast biopsy for benign breast disease (27, 28, 30). It is therefore likely that current estimates of the prevalence of proliferative breast disease and the risk of breast cancer which are based on biopsy studies reflect only the "tip of the iceberg" of the number of women with proliferative epithelial changes within the breast. In addition, be cause biopsy can only be used when clini cally indicated, it provides no information on the status of the epithelium during the earlier preclinical phases of proliferative breast disease. If new measures are to be developed for the primary prevention of breast cancer, it is important to detect and determine the causal factors of these prolif erative precursor or marker lesions in women without clinical breast findings. As noted in our introduction and from our findings, the cytologic examination of nipple aspirate fluid offers a simple, noninvasive method for this purpose.
Our findings demonstrate that women in whom hyperplasia or atypical hyperplasia was diagnosed in nipple aspirate fluids 10 18 years previously experienced a signifi cantly increased risk of breast cancer com pared with women who did not yield fluid.
The women with atypical hyperplasia were also significantly more likely to develop breast cancer than were women with normal cytologic findings. The increased risks were mostly confined to women who were aged 25-54 years at entry into the study. Of ad ditional significance was the finding that, compared with women who did not yield nipple aspirate fluid, women who yielded any fluid also had an elevated risk of breast cancer, irrespective of whether the fluid con tained normal cytology or was unsatisfactory for diagnosis. This finding was also confined to and most strikingly evident in the age group 25-54 years. These findings suggest that physiologic factors affecting the secre tion of breast fluid may be related to breast cancer risk. The lack of any consistent ele vated risk associated with abnormal epithe lial findings in women aged 55 years or older at entry into the study is likely to result from the normal, age-related process of ductal involution and the accompanying reduction in breast fluid secretion (1-4, 31). Cytologic findings are therefore likely to be more vari able and less reliable in older women.
Our ratios of observed to expected cases in the San Francisco Bay Area SEER registry were 2.9 for women with atypical hyperpla sia and 7.1 for women with both atypical hyperplasia and a first-degree family history of breast cancer. These ratios were somewhat lower in magnitude than, but similar in di rection to, those reported for breast biopsy by Dupont and Page and colleagues (15, 16) . These investigators found a relative risk of breast cancer of 5.1 with atypical hyperplasia in biopsy and of 8.9 in women with both atypical hyperplasia in breast biopsy and a family history of breast cancer compared with the overall risk to women in the At lanta, Georgia, SEER registry. In both stud ies, women with atypical hyperplasia and a first-degree relative with breast cancer had an especially high risk of breast cancer, but the number of women in our study with both atypical hyperplasia and a family his tory of breast cancer who developed breast cancer was small, 3 of 10 (30 percent), com pared with 10 of 39 (26 percent) by Dupont and Page (15) .
Several cautions should be considered in evaluating our results. Because, to our knowledge, this is the first prospective study of breast cancer risk associated with nipple aspirate cytology, additional work and ex perience in this area will be needed to con firm and extend these findings. Second, our present results probably should not be gen eralized to the population at large because our study population was not randomly se lected, but was largely composed of volun teers and a smaller proportion of women with breast complaints. However, the com parison of breast cancer risk for white women in our cohort with that of all white women in the San Francisco Bay Area in dicates that our population did not differ much in breast cancer risk from other women in the area. Finally, because this report was confined to white women, the relative risks associated with epithelial ab normalities may differ or may be modified by different behavioral, life-style, or physio logic factors in other ethnic groups. Despite these caveats, the subjects in this study are more likely to be representative of the gen eral population than are subjects in studies based on women who have undergone breast biopsy.
Because findings from nipple aspirate cy tology are often compared with findings based on breast biopsy, it is useful to discuss some differences and potential biases that may influence the results from these meth ods of investigation. As discussed earlier, it is not known if all breast cancers arise from proliferative epithelial cell precursors. Of the 80 women in our study who developed breast cancer and who had had a nipple aspirate fluid sample satisfactory for cyto logic diagnosis, 30 percent (24 of 80) were diagnosed as having epithelial hyperplasia or atypical hyperplasia. In the study of benign biopsy by Dupont and Page and colleagues (15, 16) , of the 134 women who developed breast cancer, 77 percent (103 of 134) had been diagnosed with proliferative epithe lium, with or without atypia. This compari son suggests that the finding of proliferative epithelium in nipple aspirates may be less predictive of breast cancer risk than prolif erative epithelium in breast biopsies. In the future, newer molecular markers may help us to differentiate proliferative lesions with and those without neoplastic potential.
However, before concluding that a nipple aspirate diagnosis of proliferative epithelium has a lower predictive value than that of breast biopsy, one should note that the fol low-up time in our study averaged only 12.5 years, compared with 17 years in the study by Dupont and Page and colleagues. The cumulative incidence of breast cancer from the time of nipple aspiration (figure 1) indi cates that up to 17 years after nipple aspi ration, the curve for breast cancer incidence in women diagnosed with atypical hyperpla sia is almost identical with that found for atypical hyperplasia in the biopsy study by Page et al. (16) . Our cohort will need to be revaluated in 5 years to determine if the breast cancer risks will continue to increase in women who had previously received di agnoses of proliferative changes. Finally, the fact that the majority (56 of 80) of the breast cancers among women with satisfactory cy tology developed in women with normal cytology might lead to the conclusion that most breast cancers do not arise from prolif erative lesions. It should be emphasized that nipple aspiration cytologic diagnoses are based on a very small number of breast epithelial cells. It is likely that, similar to cervical cytology, nipple aspirate diagnoses made on single samples will be subject to a high rate of false negative diagnoses. This might be overcome by the use of repeated sampling.
The opportunistic nature of the clinical findings that lead to breast biopsy is sug gested by autopsy studies demonstrating that epithelial proliferation and other benign conditions of the breast are so widely prev alent among Western women that they can almost be considered "normal variants" (32) . Many opportunities for selection bias may occur before the decision is made to Abnormal Cytology and Breast Cancer Risk 139 biopsy a suspicious breast mass. These in clude practice of breast self-examination; pa tient anxiety and delay in seeking physician consultation; availability, utilization, and interpretation of mammograms; and expe rience of the physician and surgeon in man aging breast problems. A recent study indi cated considerable interobserver variability between experienced breast pathologists in the diagnosis of this high-risk lesion (33). These considerations suggest that current estimates of risk based on the finding of atypical hyperplasia in breast biopsies are obtained from highly selected subsets of women and are likely, to a variable and indeterminate degree, to be "biased." How ever, the information derived from biopsy studies has had important clinical value for diagnosis, counseling, and prognosis, as well as for many important epidemiologic studies of benign breast disease and breast cancer. For the foreseeable future, histopathologic criteria will remain the "gold standard" for the diagnosis of precursor lesions of breast cancer, although these histologic markers are rapidly being supplemented by new immu nohistochemical and molecular markers.
As in biopsy studies, several biases may influence nipple aspirate cytology findings. Because the vast majority of women we studied were volunteers without clinically diagnosed breast disease, "volunteer bias" may have been present. Factors such as pub licity, health education, family history of breast cancer, and concerns arising from a prior history of benign breast disease might have influenced a woman's decision to vol unteer for nipple aspiration.
The fact that breast fluid cannot be ob tained by nipple aspiration from all women in whom it is attempted has also raised concerns about its clinical value. Until this study, we were unable to assess the influence of this factor on breast cancer risk. As dis cussed earlier, among women under age 55 years at entry into the study, those who yielded any fluid had greater risks of breast cancer than those who did not. Thus, failure to obtain breast fluid may not be a major biasing factor in this age group, but instead may be a physiologic marker indicative of a normal, low secretory activity. Little is known of the factors that determine the internal secretion of breast fluid in nonpreg nant, nonlactating women. Our studies on the biochemistry of breast fluid indicate that many chemical substances of exogenous and endogenous origin, including mutagens and carcinogens, are secreted into the breast duct fluid (2) . We have hypothesized that this secretory activity may increase the exposure of the breast epithelia to putative carcino genic and other chemical substances which may influence the risk of breast cancer (2, 3) . This process might increase the risk of initiation and promotion of epithelial cells to premalignant and malignant cells, possi bly by activating or inhibiting genes that control cell differentiation and proliferation.
It should be emphasized that as of the end of follow-up in April 1991, only 10.3 percent (6 of 58) of the women with cytologic atyp ical hyperplasia had developed breast can cer, indicating that additional factors must be involved in susceptibility to the disease. Studies of migrant populations; families with genetic high risk; diet and environ mental exposures; and the application of newer molecular probes and genetic markers may help to differentiate those women whose atypia is truly high risk from those whose atypia is not.
The results of this prospective study offer strong support for our hypothesis that cyto logic atypical hyperplasia and hyperplasia in nipple aspirates of breast fluid are associated with an increased risk of breast cancer. The identification of these cytologic epithelial changes indicative of high risk for breast cancer may have clinical and epidemiologic applications. For example, these high-risk cytologic lesions may be useful as interme diate outcomes in intervention studies of diet or chemoprevention. At present, we do not advocate the use of this technique as a routine diagnostic procedure. In the future, as clinicians and researchers gain more ex perience with nipple aspirate cytology, it may become possible to augment clinical counseling of women about their breast can cer risks, incorporating risk estimates based on nipple aspirate cytology. Finally, nipple aspirate cytology permits the investigation of the earlier phases of the natural history of proliferative breast disease in women who have no indication for breast biopsy. Studies of the physiologic factors that regulate breast fluid secretion, biochemistry, and cytology offer many important new opportunities for research on the etiologic factors underlying proliferative breast disease and provide new leads for the prevention of breast cancer.
